Amit K Verma
Albert Einstein College of Medicine · ECOG-ACRIN Cancer Research Group
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Amit K Verma as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:58 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT01772420 · Phase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic AnemiaAlbert Einstein College of Medicine · completed · Adult Myelodysplastic Syndrome, Anemia, Chronic Myelomonocytic Leukemia · principal investigator
- Ph3NCT00843882 · Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and AnemiaNational Cancer Institute (NCI) · active not recruiting · Anemia, Chronic Myelomonocytic Leukemia, De Novo Myelodysplastic Syndrome · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:58 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Blood mutations and cancer associations among WTC-exposed FirefightersR21OH012947 · NIOSH · ALBERT EINSTEIN COLLEGE OF MEDICINE · fiscal years 2025 to 2026 · $217,614 awarded in 2026Same name and institution; not confirmed by an ID
- Montefiore Einstein Clinical Oncology Training Program in the BronxK12CA279871 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE · fiscal years 2023 to 2026 · $707,977 awarded in 2026Same name and institution; not confirmed by an ID
- Therapeutic targeting of IRAK4 in MDSR01CA275007 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE · fiscal years 2022 to 2026 · $528,022 awarded in 2026Same name and institution; not confirmed by an ID
- EARLY DETECTION OF CLONAL HEMATOPOIESIS AND LEUKEMIA ASSOCIATED MUTATIONS IN WTC EXPOSED FIREFIGHTERS AFTER THE 9/11 ATTACKSU01OH012271 · NIOSH · ALBERT EINSTEIN COLLEGE OF MEDICINE · fiscal years 2021 to 2023 · $488,632 awarded in 2023Same name and institution; not confirmed by an ID
- STAT3 inhibition as a therapeutic strategy against MDS stem cellsR01HL150832 · NHLBI · ALBERT EINSTEIN COLLEGE OF MEDICINE · fiscal years 2019 to 2022 · $531,973 awarded in 2022Same name and institution; not confirmed by an ID
- Therapeutic targeting of MDS stem cellsR01HL139487 · NHLBI · ALBERT EINSTEIN COLLEGE OF MEDICINE · fiscal years 2018 to 2021 · $528,896 awarded in 2021Same name and institution; not confirmed by an ID
- Cooperative Research Agreements Related to the World Trade Center Health Program (U01)U01OH011933 · NIOSH · ALBERT EINSTEIN COLLEGE OF MEDICINE · fiscal years 2019 · $499,807 awarded in 2019Same name and institution; not confirmed by an ID
- Paul Calabresi Career Development Award for Clinical Oncology (K12)K12CA132783 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE · fiscal years 2019 · $774,407 awarded in 2019Same name and institution; not confirmed by an ID
- Early Detection of Hematologic Malignancies in New York City Firefighters Exposed To World Trade Center Dust After The 9/11 AttacksU01OH011475 · NIOSH · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · fiscal years 2017 to 2018 · $499,807 awarded in 2018Same name and institution; not confirmed by an ID
- Therapeutic targeting of MicroRNA-21 in Myelodysplastic syndromesR01DK103961 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · fiscal years 2014 to 2017 · $358,005 awarded in 2017Same name and institution; not confirmed by an ID
- p38 MAPK as a therapeutic target in Myelodysplastic syndromeR01HL082946 · NHLBI · ALBERT EINSTEIN COLLEGE OF MEDICINE · fiscal years 2005 to 2009 · $111,851 awarded in 2009Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Biostatistics Shared ResourceP30CA013330 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI XIAONAN NA XUE · fiscal years 2009 to 2026Named on NCT01772420
- Eastern Cooperative Oncology Group Operations OfficeU10CA021115 · NCI · FRONTIER SCI & TECHNOLOGY RSCH FDN, INC · PI ROBERT L COMIS · fiscal years 2009 to 2013Named on NCT00843882
- ECOG-ACRIN Network Group Operations CenterU10CA180820 · NCI · ECOG-ACRIN MEDICAL RESEARCH FOUNDATION · PI Peter J ODwyer, MITCHELL D. SCHNALL · fiscal years 2014 to 2026Named on NCT00843882
- ECOG-ACRIN Biospecimen Bank to Support NCTNU24CA196172 · NCI · ECOG-ACRIN MEDICAL RESEARCH FOUNDATION · PI STANLEY R. HAMILTON, Scott D Jewell · fiscal years 2015 to 2026Named on NCT00843882
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:58 UTC. The ranking covers the 200 most relevant of 29 PubMed records, and a shared surname and initials can bring in a namesake. All 29 on PubMed
- Randomized phase I chemoprevention dose-seeking study of alpha-difluoromethylornithine.J Natl Cancer Inst · 199394 citationsRCR 3.0
- A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer.Cancer Prev Res (Phila) · 201088 citationsRCR 2.5
- Improvement of limb circulation in peripheral vascular disease using epidural spinal cord stimulation: a prospective study.J Neurosurg · 199758 citationsRCR 2.8
- A randomized, placebo-controlled trial of low-dose alpha-difluoromethylornithine in individuals at risk for colorectal cancer.Cancer Epidemiol Biomarkers Prev · 199850 citationsRCR 1.4
- Quality of life (QoL) in patients with benign thyroid goiters (pre- and post-thyroidectomy): a prospective study.World J Surg · 201345 citationsRCR 2.1
- 45 citationsRCR 1.1
- Phase I chemoprevention study of piroxicam and alpha-difluoromethylornithine.Cancer Epidemiol Biomarkers Prev · 199840 citationsRCR 1.1
- Diuretic effects of subcutaneous furosemide in human volunteers: a randomized pilot study.Ann Pharmacother · 200439 citationsRCR 1.1
- Prospective study to compare peri-operative hemodynamic alterations following preparation for pheochromocytoma surgery by phenoxybenzamine or prazosin.World J Surg · 201439 citationsRCR 2.0
- Effect of dietary supplementation of omega-3 polyunsaturated fatty acid (PUFA) rich fish oil on reproductive performance of the goat (Capra hircus).Theriogenology · 201737 citationsRCR 2.7